Overview
CVS Health Corporation, based in the United States, operates as an integrated healthcare company primarily engaging in the pharmacy services and retail drugstore sectors. It offers a broad range of services including pharmacy benefit management, retail and long-term care pharmacy services, and healthcare services through its walk-in medical clinics. A notable element of CVS Health's strategic endeavor is its expansion into health insurance, exemplified by its acquisition of Aetna, one of the nation's leading diversified healthcare benefits companies. This move has substantially broadened its healthcare offering, reinforcing CVS's position in managing pharmaceutical costs and extending its healthcare delivery capabilities. CVS Health’s initiatives aim to improve access to quality care and deliver better health outcomes while managing costs effectively.
AI+ Ask Fintel’s AI assistant about CVS Health Corporation.
Thinking about good questions…
Basic Stats
The Factor Analysis chart (below right) shows a view of CVS Health Corporation from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | |
| EV | |
| Shares Out. | 1,310.00 MM |
| Earnings Date | |
| EPS (TTM) | |
| Dividend Yield | |
| Ex-Dividend Date | 2025-07-22 |
| Borrow Rate | |
| Short Shares Avail. | 0.00 MM |
| Short Interest | |
| Short Float | |
| Days to Cover | |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | |
| Volatility (1 yr) | |
| Beta | |
| Sharpe Ratio (1 yr) | |
| Sortino Ratio (1 yr) |
| PE Ratio | |
| Price/Book | |
| Price/TBV | |
| Book/Market | |
| EBIT/EV | |
| EBIT(3yr avg)/EV | |
| ROA | 0.00 |
| ROE | 0.00 |
| ROIC | 0.00 |
| CROIC | 0.03 |
| OCROIC | 0.00 |
| Implied Volatility | |
| Put/Call OI Ratio |
| Growth | |
| Profitability | |
| Quality Score | |
| Value Score | |
| Momentum Score | |
| Stability (Low Vol) Score | |
| Analyst Sentiment | |
| Fund Sentiment | |
| Insider Sentiment | |
| Officer Sentiment | |
| Dividend Score | |
| QVM Score | |
| Piotroski F-SCORE | 0.00 /9 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for CVS Health Corporation is MX$1,531.35. The forecasts range from a low of MX$1,328.71 to a high of MX$1,953.61. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for CVS Health Corporation. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2024-08-08 | Cantor Fitzgerald | Neutral | Neutral | Maintains |
| 2024-08-08 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2024-08-08 | Evercore ISI Group | Outperform | Outperform | Maintains |
| 2024-08-09 | Deutsche Bank | Hold | Hold | Maintains |
| 2025-08-01 | Barclays | Overweight | Overweight | Maintains |
| 2025-08-01 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2024-08-12 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2024-09-10 | Cantor Fitzgerald | Neutral | Neutral | Reiterate |
| 2024-06-12 | Cantor Fitzgerald | Neutral | Neutral | Reiterate |
| 2024-05-30 | JP Morgan | Overweight | Overweight | Maintains |
| 2024-05-30 | Baird | Neutral | Initiate | |
| 2024-05-08 | Argus Research | Buy | Buy | Maintains |
| 2024-05-07 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2024-05-07 | TD Cowen | Buy | Hold | Downgrade |
| 2024-05-02 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2024-05-02 | Goldman Sachs | Buy | Buy | Maintains |
| 2024-05-02 | B of A Securities | Buy | Buy | Maintains |
| 2024-05-02 | Truist Securities | Buy | Buy | Reiterate |
| 2024-05-02 | UBS | Buy | Neutral | Downgrade |
| 2024-05-02 | Mizuho | Buy | Buy | Maintains |
| 2024-05-01 | Cantor Fitzgerald | Overweight | Neutral | Downgrade |
| 2024-05-01 | Leerink Partners | Outperform | Market Perform | Downgrade |
| 2024-04-10 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-04-08 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2024-04-04 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-03-15 | Piper Sandler | Overweight | Overweight | Maintains |
| 2024-03-06 | Barclays | Equal-Weight | Initiate | |
| 2024-02-26 | Leerink Partners | Outperform | Initiate | |
| 2024-02-08 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-02-08 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2023-12-22 | HSBC | Buy | Initiate | |
| 2023-12-11 | TD Cowen | Outperform | Outperform | Maintains |
| 2023-11-21 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2023-11-02 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2023-11-02 | RBC Capital | Outperform | Outperform | Maintains |
| 2023-09-19 | Evercore ISI Group | In-Line | Outperform | Upgrade |
| 2023-09-14 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2023-09-12 | Wolfe Research | Peer Perform | Outperform | Upgrade |
| 2023-09-01 | Piper Sandler | Overweight | Overweight | Maintains |
| 2023-08-18 | RBC Capital | Outperform | Outperform | Reiterate |
| 2023-08-18 | Edward Jones | Buy | Hold | Downgrade |
| 2023-08-04 | Raymond James | Outperform | Outperform | Maintains |
| 2023-08-03 | Truist Securities | Buy | Buy | Maintains |
| 2023-08-03 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2023-08-03 | RBC Capital | Outperform | Outperform | Maintains |
| 2023-08-03 | Barclays | Overweight | Overweight | Maintains |
| 2023-07-12 | Barclays | Overweight | Overweight | Maintains |
| 2023-07-11 | Mizuho | Buy | Buy | Maintains |
| 2023-07-07 | JP Morgan | Overweight | Overweight | Maintains |
| 2023-06-20 | Truist Securities | Buy | Buy | Maintains |
| 2023-05-30 | JP Morgan | Overweight | Overweight | Maintains |
| 2023-05-26 | Piper Sandler | Overweight | Initiate | |
| 2014-11-05 | FBR Capital | Outperform | Maintains | |
| 2014-09-15 | Cowen & Co. | Market Perform | Outperform | Upgrade |
| 2014-08-06 | JP Morgan | Overweight | Maintains | |
| 2014-08-06 | Barclays | Overweight | Maintains | |
| 2014-05-05 | Barclays | Overweight | Maintains | |
| 2014-01-22 | ISI Group | Buy | Strong Buy | Upgrade |
| 2014-01-09 | Leerink Swann | Outperform | Initiate | |
| 2013-12-20 | Deutsche Bank | Hold | Maintains | |
| 2013-12-19 | Morgan Stanley | Overweight | Maintains | |
| 2013-12-11 | Credit Suisse | Outperform | Maintains | |
| 2023-05-09 | RBC Capital | Outperform | Reiterate | |
| 2023-05-08 | Wells Fargo | Equal-Weight | Maintains | |
| 2023-05-08 | Credit Suisse | Outperform | Maintains | |
| 2023-05-08 | Raymond James | Outperform | Maintains | |
| 2023-05-05 | Goldman Sachs | Buy | Maintains | |
| 2023-05-04 | Goldman Sachs | Buy | Maintains | |
| 2023-05-04 | Barclays | Overweight | Maintains | |
| 2023-05-02 | UBS | Buy | Maintains | |
| 2023-05-02 | Bernstein | Market Perform | Maintains | |
| 2023-04-21 | Cantor Fitzgerald | Overweight | Initiate | |
| 2023-04-18 | TD Cowen | Outperform | Maintains | |
| 2023-03-31 | B of A Securities | Buy | Maintains | |
| 2023-03-30 | Barclays | Overweight | Maintains | |
| 2023-02-09 | RBC Capital | Outperform | Reiterate | |
| 2023-02-09 | Jefferies | Buy | Maintains | |
| 2023-02-09 | Raymond James | Outperform | Maintains | |
| 2023-02-09 | Barclays | Overweight | Maintains | |
| 2012-11-07 | Barclays | Overweight | Maintains | |
| 2012-11-07 | BMO Capital | Outperform | Maintains | |
| 2012-11-07 | Jefferies | Buy | Maintains | |
| 2012-11-06 | Jefferies | Buy | Maintains | |
| 2012-11-06 | ISI Group | Overweight | Maintains | |
| 2012-08-14 | Cantor Fitzgerald | Buy | Initiate | |
| 2012-08-08 | Jefferies | Buy | Maintains | |
| 2012-08-08 | Citigroup | Buy | Maintains | |
| 2012-08-08 | JP Morgan | Overweight | Maintains | |
| 2012-08-07 | ISI Group | Overweight | Maintains | |
| 2012-07-12 | ISI Group | Overweight | Initiate | |
| 2012-05-03 | UBS | Buy | Maintains | |
| 2012-05-03 | Jefferies | Buy | Maintains | |
| 2012-03-07 | Morgan Stanley | Overweight | Maintains | |
| 2012-02-09 | UBS | Buy | Maintains | |
| 2012-02-09 | Goldman Sachs | Buy | Maintains | |
| 2012-02-08 | Citigroup | Buy | Maintains | |
| 2023-01-13 | Morgan Stanley | Overweight | Maintains | |
| 2023-01-03 | Wells Fargo | Equal-Weight | Maintains | |
| 2023-01-03 | Evercore ISI Group | Outperform | In-Line | Downgrade |
| 2022-11-21 | Credit Suisse | Outperform | Maintains | |
| 2022-11-08 | Wells Fargo | Equal-Weight | Maintains | |
| 2022-11-07 | RBC Capital | Outperform | Maintains | |
| 2022-11-07 | Raymond James | Outperform | Maintains | |
| 2022-11-03 | JP Morgan | Overweight | Maintains | |
| 2022-11-03 | Goldman Sachs | Buy | Maintains | |
| 2022-10-20 | B of A Securities | Buy | Maintains | |
| 2022-10-11 | Morgan Stanley | Overweight | Maintains | |
| 2022-09-07 | Evercore ISI Group | Outperform | Maintains | |
| 2022-08-15 | Mizuho | Buy | Maintains | |
| 2022-08-08 | Credit Suisse | Outperform | Maintains | |
| 2022-08-04 | UBS | Buy | Maintains | |
| 2022-06-17 | Loop Capital | Buy | Initiate | |
| 2022-05-27 | Bernstein | Outperform | Market Perform | Downgrade |
| 2022-05-05 | Deutsche Bank | Hold | Maintains | |
| 2022-05-05 | Morgan Stanley | Overweight | Maintains | |
| 2022-03-29 | Deutsche Bank | Buy | Hold | Downgrade |
| 2022-02-14 | Raymond James | Strong Buy | Outperform | Downgrade |
| 2021-12-23 | Tigress Financial | Buy | Maintains | |
| 2021-12-20 | Mizuho | Buy | Maintains | |
| 2021-12-14 | Goldman Sachs | Buy | Initiate | |
| 2021-12-13 | Wells Fargo | Equal-Weight | Maintains | |
| 2021-12-13 | Morgan Stanley | Overweight | Maintains | |
| 2021-12-10 | Mizuho | Buy | Maintains | |
| 2021-12-10 | Credit Suisse | Outperform | Maintains | |
| 2021-12-06 | Morgan Stanley | Overweight | Maintains | |
| 2021-12-01 | Seaport Global | Buy | Initiate | |
| 2021-11-10 | Mizuho | Buy | Maintains | |
| 2021-11-05 | Credit Suisse | Outperform | Maintains | |
| 2021-11-04 | RBC Capital | Outperform | Maintains | |
| 2021-11-04 | Barclays | Overweight | Maintains | |
| 2021-11-04 | Raymond James | Strong Buy | Maintains | |
| 2021-08-31 | Morgan Stanley | Overweight | Maintains | |
| 2021-06-22 | Deutsche Bank | Buy | Maintains | |
| 2021-05-19 | Wolfe Research | Outperform | Maintains | |
| 2021-05-19 | BMO Capital | Market Perform | Maintains | |
| 2021-05-19 | Barclays | Overweight | Maintains | |
| 2021-05-19 | Wells Fargo | Equal-Weight | Initiate | |
| 2021-05-12 | Mizuho | Buy | Maintains | |
| 2021-05-06 | BMO Capital | Market Perform | Maintains | |
| 2021-05-06 | Credit Suisse | Outperform | Maintains | |
| 2021-05-05 | Raymond James | Strong Buy | Maintains | |
| 2021-04-14 | Truist Securities | Buy | Maintains | |
| 2021-04-14 | Morgan Stanley | Overweight | Maintains | |
| 2021-03-17 | Guggenheim | Buy | Neutral | Downgrade |
| 2021-01-08 | Jefferies | Hold | Buy | Upgrade |
| 2020-12-14 | SVB Leerink | Market Perform | Maintains | |
| 2020-09-17 | Piper Sandler | Overweight | Initiate | |
| 2020-08-07 | Credit Suisse | Outperform | Maintains | |
| 2020-08-06 | SVB Leerink | Market Perform | Maintains | |
| 2020-07-01 | SVB Leerink | Market Perform | Initiate | |
| 2020-05-14 | Credit Suisse | Neutral | Outperform | Upgrade |
| 2020-05-07 | Baird | Neutral | Maintains | |
| 2020-05-07 | UBS | Buy | Maintains | |
| 2020-05-07 | Citigroup | Buy | Maintains | |
| 2020-05-07 | Morgan Stanley | Overweight | Maintains | |
| 2020-05-04 | JP Morgan | Overweight | Maintains | |
| 2020-04-13 | SunTrust Robinson Humphrey | Buy | Maintains | |
| 2020-04-13 | Morgan Stanley | Overweight | Maintains | |
| 2020-03-27 | Morgan Stanley | Overweight | Maintains | |
| 2020-03-27 | Baird | Neutral | Maintains | |
| 2020-02-18 | Deutsche Bank | Buy | Maintains | |
| 2020-02-14 | Citigroup | Buy | Maintains | |
| 2020-02-13 | CFRA | Strong Buy | Maintains | |
| 2020-02-13 | UBS | Buy | Maintains | |
| 2020-02-13 | Baird | Neutral | Maintains | |
| 2020-02-13 | Cantor Fitzgerald | Overweight | Maintains | |
| 2020-02-12 | CFRA | Strong Buy | Maintains | |
| 2019-12-04 | Raymond James | Strong Buy | Reiterate | |
| 2019-11-22 | Morgan Stanley | Overweight | Maintains | |
| 2019-11-18 | SunTrust Robinson Humphrey | Buy | Maintains | |
| 2019-11-08 | Wells Fargo | Market Perform | Maintains | |
| 2019-11-07 | Citi | Buy | Maintains | |
| 2019-11-07 | Raymond James | Strong Buy | Maintains | |
| 2019-11-07 | UBS | Buy | Maintains | |
| 2019-11-07 | Barclays | Overweight | Maintains | |
| 2019-11-07 | Citigroup | Buy | Maintains | |
| 2019-09-26 | Morgan Stanley | Overweight | Maintains | |
| 2019-09-12 | Bank of America | Buy | Maintains | |
| 2019-09-12 | Deutsche Bank | Buy | Initiate | |
| 2019-08-27 | Cowen & Co. | Outperform | Reiterate | |
| 2019-05-02 | UBS | Buy | Buy | Maintains |
| 2019-04-29 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2019-04-18 | Raymond James | Strong Buy | Strong Buy | Maintains |
| 2019-04-18 | Guggenheim | Buy | Initiate | |
| 2019-04-15 | Oppenheimer | Outperform | Perform | Downgrade |
| 2019-04-11 | BMO Capital | Outperform | Initiate | |
| 2019-03-13 | Bernstein | Outperform | Initiate | |
| 2019-03-06 | Citigroup | Buy | Buy | Maintains |
| 2019-02-21 | UBS | Buy | Buy | Maintains |
| 2019-01-17 | UBS | Buy | Initiate | |
| 2018-12-18 | Barclays | Overweight | Initiate | |
| 2018-11-27 | Cantor Fitzgerald | Overweight | Initiate | |
| 2018-10-26 | Wolfe Research | Peer Perform | Initiate | |
| 2018-09-17 | Bank of America | Buy | Buy | Maintains |
| 2018-07-05 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2018-07-03 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2018-04-11 | Bank of America | Buy | Buy | Maintains |
| 2018-02-13 | Citigroup | Neutral | Neutral | Maintains |
| 2018-02-09 | Leerink Swann | Outperform | Outperform | Maintains |
| 2018-02-09 | Baird | Neutral | Neutral | Maintains |
| 2018-01-05 | Morgan Stanley | Equal-Weight | Overweight | Upgrade |
| 2018-01-04 | Raymond James | Outperform | Strong Buy | Upgrade |
| 2017-12-04 | Deutsche Bank | Buy | Initiate | |
| 2017-11-13 | Citigroup | Neutral | Maintains | |
| 2017-11-10 | Needham | Hold | Buy | Upgrade |
| 2017-11-07 | Loop Capital | Hold | Maintains | |
| 2017-11-07 | Leerink Swann | Outperform | Maintains | |
| 2017-11-07 | Jefferies | Hold | Maintains | |
| 2017-11-03 | Citigroup | Neutral | Maintains | |
| 2017-09-19 | RBC Capital | Outperform | Initiate | |
| 2017-09-15 | Jefferies | Hold | Maintains | |
| 2017-08-25 | Loop Capital | Hold | Initiate | |
| 2017-08-17 | Citigroup | Neutral | Maintains | |
| 2017-08-14 | Wolfe Research | Outperform | Peer Perform | Downgrade |
| 2017-06-28 | Needham | Hold | Initiate | |
| 2017-04-28 | Tigress Financial | Buy | Initiate | |
| 2017-04-27 | Tigress Financial | Buy | Initiate | |
| 2017-02-02 | Baird | Outperform | Neutral | Downgrade |
| 2016-10-06 | UBS | Buy | Initiate | |
| 2016-10-03 | Bank of America | Buy | Maintains | |
| 2016-10-03 | Baird | Outperform | Maintains | |
| 2016-08-08 | Citigroup | Neutral | Maintains | |
| 2016-08-03 | Deutsche Bank | Hold | Maintains | |
| 2016-05-12 | Jefferies | Buy | Maintains | |
| 2016-05-09 | Citigroup | Neutral | Maintains | |
| 2016-02-03 | Atlantic Equities | Overweight | Initiate | |
| 2016-01-22 | Baird | Outperform | Initiate | |
| 2015-12-17 | Goldman Sachs | Buy | Neutral | Downgrade |
| 2015-11-02 | JP Morgan | Overweight | Maintains | |
| 2015-11-02 | Oppenheimer | Outperform | Maintains | |
| 2015-08-28 | Oppenheimer | Outperform | Maintains | |
| 2015-06-18 | Oppenheimer | Outperform | Initiate | |
| 2015-06-10 | Cowen & Co. | Outperform | Maintains | |
| 2015-06-09 | Macquarie | Outperform | Initiate | |
| 2015-04-27 | Jefferies | Buy | Maintains | |
| 2015-02-13 | Deutsche Bank | Hold | Maintains | |
| 2015-02-13 | Citigroup | Neutral | Maintains | |
| 2015-01-21 | Goldman Sachs | Neutral | Buy | Upgrade |
| 2015-01-08 | JP Morgan | Overweight | Maintains | |
| 2015-01-02 | Bank of America | Buy | Maintains | |
| 2014-12-17 | Credit Suisse | Outperform | Maintains | |
| 2014-12-17 | Barclays | Overweight | Maintains | |
| 2014-12-17 | JP Morgan | Overweight | Maintains | |
| 2014-12-10 | Citigroup | Neutral | Initiate | |
| 2014-11-05 | Deutsche Bank | Hold | Maintains | |
| 2013-11-29 | Morgan Stanley | Overweight | Maintains | |
| 2013-11-20 | Deutsche Bank | Hold | Initiate | |
| 2013-11-06 | BMO Capital | Outperform | Maintains | |
| 2013-10-07 | Jefferies | Buy | Initiate | |
| 2013-09-13 | Cowen & Co. | Market Perform | Initiate | |
| 2013-08-07 | Cantor Fitzgerald | Buy | Hold | Downgrade |
| 2013-05-31 | Wells Fargo | Outperform | Initiate | |
| 2013-04-24 | Citigroup | Buy | Maintains | |
| 2013-04-14 | Goldman Sachs | Neutral | Maintains | |
| 2013-03-12 | Goldman Sachs | Buy | Neutral | Downgrade |
| 2012-12-20 | Jefferies | Buy | Maintains | |
| 2012-12-14 | UBS | Buy | Maintains | |
| 2012-12-14 | Macquarie | Neutral | Outperform | Upgrade |
| 2012-12-14 | JP Morgan | Overweight | Maintains | |
| 2012-12-14 | Credit Suisse | Outperform | Maintains | |
| 2012-12-14 | Morgan Stanley | Overweight | Maintains | |
| 2012-12-14 | Cantor Fitzgerald | Buy | Maintains | |
| 2012-12-13 | ISI Group | Overweight | Maintains | |
| 2024-11-25 | TD Cowen | Buy | Buy | Maintains |
| 2024-11-25 | Piper Sandler | Overweight | Overweight | Maintains |
| 2024-11-20 | Truist Securities | Buy | Buy | Reiterate |
| 2024-11-18 | Wells Fargo | Equal-Weight | Overweight | Upgrade |
| 2024-11-15 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-09-04 | RBC Capital | Outperform | Outperform | Reiterate |
| 2025-06-30 | Jefferies | Buy | Buy | Maintains |
| 2024-09-16 | Cantor Fitzgerald | Neutral | Neutral | Reiterate |
| 2025-04-15 | Baird | Neutral | Neutral | Maintains |
| 2024-10-04 | TD Cowen | Hold | Buy | Upgrade |
| 2024-10-24 | Mizuho | Outperform | Outperform | Maintains |
| 2024-10-23 | Barclays | Overweight | Overweight | Maintains |
| 2024-07-23 | Cantor Fitzgerald | Neutral | Neutral | Reiterate |
| 2024-12-03 | Deutsche Bank | Hold | Buy | Upgrade |
| 2024-08-19 | Cantor Fitzgerald | Neutral | Neutral | Reiterate |
| 2024-11-07 | Barclays | Overweight | Overweight | Maintains |
| 2024-11-07 | UBS | Neutral | Neutral | Maintains |
| 2024-11-04 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2025-04-11 | Truist Securities | Buy | Buy | Maintains |
| 2025-02-18 | JP Morgan | Overweight | Overweight | Maintains |
| 2024-10-10 | Barclays | Equal-Weight | Overweight | Upgrade |
| 2024-10-08 | Evercore ISI Group | Outperform | Outperform | Maintains |
| 2025-02-13 | Wells Fargo | Overweight | Overweight | Maintains |
| 2025-02-13 | Barclays | Overweight | Overweight | Maintains |
| 2025-02-13 | Truist Securities | Buy | Buy | Maintains |
| 2025-02-13 | Leerink Partners | Market Perform | Outperform | Upgrade |
| 2025-01-06 | Truist Securities | Buy | Buy | Maintains |
| 2024-10-11 | Truist Securities | Buy | Buy | Maintains |
| 2025-01-27 | Evercore ISI Group | Outperform | Outperform | Maintains |
| 2024-10-01 | Cantor Fitzgerald | Neutral | Neutral | Reiterate |
| 2025-05-02 | UBS | Neutral | Neutral | Maintains |
| 2025-03-21 | Piper Sandler | Overweight | Overweight | Maintains |
| 2025-04-09 | Mizuho | Outperform | Outperform | Maintains |
| 2025-05-12 | Truist Securities | Buy | Buy | Maintains |
| 2025-05-02 | Barclays | Overweight | Overweight | Maintains |
| 2025-08-14 | Baird | Neutral | Outperform | Upgrade |
| 2025-06-02 | Barclays | Overweight | Overweight | Maintains |
| 2025-09-04 | Barclays | Overweight | Overweight | Maintains |
| 2025-05-06 | Wells Fargo | Overweight | Overweight | Maintains |
| 2025-05-05 | RBC Capital | Outperform | Outperform | Maintains |
| 2025-07-22 | UBS | Neutral | Neutral | Maintains |
| 2025-08-18 | UBS | Neutral | Buy | Upgrade |
| 2025-09-05 | Bernstein | Market Perform | Market Perform | Maintains |
| 2025-08-26 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
